Report Archive
All Research
Page 16 of 43 · 1027 reports
27/100
Victrex (VCT.LSE) Zen Horizon Framework Deep Dive: The World's PEEK King Has Fallen 80%—A Great Asset Meets Structural Price Resets, a China Plant Write-Down, and a Dividend Cut Hanging Overhead
The world's largest maker of PEEK (a high-performance engineering plastic), Victrex builds metal-replacement specialty polymers sold into aerospace, medical, electronics, and automotive; its leadership position, vertical integration, and Invibio implant-grade medical franchise (~75% gross margin) form a real moat. It is now hitting a structural pricing reset from low-cost Chinese PEEK (roughly half the import price)—volumes are rising but profits are falling, and underlying operating margin has been halved from 28% to 16.5%. Rating Watch: a world-class asset facing structural margin erosion and a likely dividend cut, cheap but not yet safe.
41/100
AeroVironment (AVAV) Zen Horizon Research Report
AeroVironment is a core U.S. supplier of loitering munitions (Switchblade) and small drones (Puma/Raven), positioned directly in the strongest defense tailwind of this cycle: drone dominance. The central thesis is that a first-rate franchise is meeting a costly integration stumble after the $4.1 billion all-stock BlueHalo acquisition, with the Q3 revenue miss, gross margin compression from 38% to 24%, a $151 million space goodwill impairment, lowered full-year guidance, a GAAP loss, and securities class-action litigation all surfacing at once. Rating Watch: a durable compounder in a powerful market, but the better entry point is after integration stabilizes or below $175.
46/100
BWX Technologies (BWXT) Zen Horizon Research Report
BWX Technologies is the de facto sole-source manufacturer of U.S. Navy nuclear propulsion reactors, cores, and fuel, with a nearly impregnable moat. The core thesis is anchored by roughly $7 billion of government backlog and rigid multi-year national programs such as the Columbia- and Virginia-class submarines, with additional nuclear renaissance options in Project Pele microreactors, BWRX-300 reactor pressure vessels, and medical isotopes. Report rating Watch: a world-class business is already priced close to full value, leaving limited margin of safety before option value converts into earnings.
35/100
Archer Aviation (ACHR.US) Zen Horizon Research Report
Archer Aviation is the second major global eVTOL air-taxi contender, with a market cap of about $4.85 billion, net cash of about $1.7 billion ($2.23/share), and EV of about $3.15 billion. FAA certification has closed Stage 3 and net cash covers roughly two years, but the company still has almost no commercial revenue, burns more than $600 million a year, has expanded its share count by 166% in two years, and trails Joby by roughly one certification stage. Rating Watch: after falling by half to $6.38, the stock still lacks a margin of safety.
47/100
Samsung Biologics (207940) Zen Horizon Framework Deep Dive: A Global CDMO Champion Newly Purified by Spin-Off, Where an Excellent Business Meets a Rich Price and Unproven BIOSECURE Upside
Samsung Biologics is the world's largest biologics CDMO, a contract development and manufacturing platform that became a pure-play CDMO after spinning off Samsung Bioepis in November 2025. Its core case rests on world-leading capacity of roughly 780,000 liters, operating margin near 45%, revenue growth above 30%, relationships with 17 of the world's top 20 pharmaceutical companies, and a $21.4B backlog, but the valuation already prices in capacity leadership and BIOSECURE upside that has not yet been proven in orders. Report rating Hold: a top-tier compounder deserves a premium, but at the current price the margin of safety is thin.
35/100
JL MAG Rare-Earth (300748) Zen Horizon Framework Deep Dive: A Global Rare-Earth Permanent Magnet Leader, With a V-Shaped Earnings Rebound Meeting a Rich Valuation and a Robotics Narrative
JL MAG Rare-Earth is the clear A-share leader in rare-earth permanent magnets, focused on high-performance NdFeB materials for NEVs, inverter air conditioners, wind power, and robotics. The core thesis is a V-shaped earnings rebound, with 2024 attributable net profit of CNY 290 million rising to CNY 706 million in 2025, driven mainly by higher praseodymium-neodymium prices and EV volume growth. Report rating Watch: a high-quality cyclical leader whose good news and unproven robotics option are already largely prepaid in the share price.
27/100
Sunshine Silver Mining & Refining (SSMR): A Zen Horizon Deep Dive
A development-stage silver miner that listed on 2026-06-04, anchored by Idaho's historic Sunshine silver mine (about 264 million ounces of silver resource, zero reserves, only a PEA-level initial assessment). Record-high silver prices plus a domestic U.S. antimony option are the bright spots, but production is unlikely before late 2028 and multiple rounds of dilution will be needed before then. Rating Watch: a genuinely good asset priced far too early and far too richly, with no margin of safety at the current price.
36/100
Roche Zen Horizon Framework Deep Dive: A Diagnostics and Pharma Giant Past the Patent Cliff, with a Fair Price and Debated Growth
Roche is the global leader in in vitro diagnostics and a top-tier pharmaceutical company in oncology, neurology, and ophthalmology, with family control and CHF-denominated shares. The company has moved past its patent cliff, new medicines have filled an approximately USD 10 billion gap, and the group has returned to +7% constant-currency growth, though a strong Swiss franc has reduced reported growth to only +2% in CHF. Rating Hold: valuation is fair at roughly 16x forward PE with a 3% dividend, 27% below the 2022 high, while growth remains debated and obesity is the largest upside option.
43/100
Schrödinger (SDGR) Zen Horizon Research Report
Schrödinger is a physics-based computational drug discovery platform built around FEP+, a gold-standard method, with 19 of the world's top 20 pharma companies as software customers and additional upside from internal and partnered pipelines plus repeat equity monetizations. Its current market value is about $1.1 billion, with roughly $300 million of net cash, while the stock is down 86% from its 2021 peak. Research rating Hold: a real platform with a hard moat and cheap parts, but slower software growth and limited near-term catalysts keep the risk-reward balanced.
38/100
Hon Hai Precision (2317.TW) Zen Horizon Deep-Dive Research
The world's largest electronics manufacturing services (EMS) leader is being re-rated as AI servers, including roughly a 40% share in NVL72 racks, lift cloud and networking revenue above iPhone-related revenue for the first time. Yet gross margin is only 6% and net margin 2%, the profit pool sits with Nvidia rather than the assembler, PE-TTM is around 20x at a ten-year high, and the margin of safety is thin. Rating Hold: the ideal buy zone requires a pullback to below roughly TWD 220.
46/100
SiTime (SITM) Zen Horizon Research Report
SiTime is the only scaled MEMS precision-timing player globally, replacing quartz crystal oscillators at the physical-material level with silicon-based oscillators. Its MEMS segment share exceeds 80%, while AI data centers drove Q1'26 revenue up 88% and FY26 guidance to at least 80% growth, though the $3.2 billion acquisition of Renesas's timing business adds leverage, dilution, and integration uncertainty. Research rating Watch: a real moat and real growth, but the current price leaves little margin for error.
36/100
GlobalFoundries (GFS) Zen Horizon Research Report
GlobalFoundries is the only Western pure-play foundry with manufacturing capacity across the United States, Europe, and Singapore, built around RF-SOI, FD-SOI, automotive, power, silicon photonics, and trusted manufacturing. The core thesis is a scarce reshoring and silicon-photonics positioning offset by a mature-node foundry model with only 26% gross margin, far below TSMC's 62%, and cyclical revenue. Research rating Watch: a real strategic asset, but the stock has already moved ahead of Wall Street consensus and fundamental growth.
43/100
Sanhua Intelligent Controls (002050.SHE) Zen Horizon Deep-Dive Research
Sanhua Intelligent Controls is the global leader in refrigeration control components, a new-energy vehicle thermal-management Tier-1 supplier, and an actuator option on humanoid robotics. FY25 revenue reached 31.0 billion yuan, attributable net profit was 4.06 billion yuan (+31%), gross margin was 28.8%, ROE was 15.8%, and the balance sheet was close to net cash. Research rating Watch: a high-quality manufacturer at a demanding price, with too much value already assigned to an unproven robotics option.
37/100
Cognex Zen Horizon Framework Deep Dive: The Eyes of Machine Vision, a Great Business at an Expensive Price
Cognex is the world's second-largest machine-vision leader, with a 68% gross margin, a 24% FCF margin, zero debt, and Q1 revenue reaccelerating by 24%. The core issue is valuation: 76× TTM PE and 44× forward PE sit near the top of its historical range, at a premium to every comparable company, mostly by 2-3×, while the share price has doubled in six months and leaves no margin of safety. Research rating Watch: a high-quality business at an expensive price, with the real entry point around $40-49.
53/100
Credo (CRDO) Zen Horizon Report
The pioneer of the AI data center copper interconnect category (Active Electrical Cable, AEC) and the leader with roughly 75% share. FY2026 revenue tripled to $1.335 billion, with a 68% gross margin, 35% GAAP net margin, $1.4 billion in net cash, and almost no debt—a connectivity picks-and-shovels play that is top tier on both quality and growth. Rating Watch: a superb business bought at a price that has already prepaid years of flawless growth, with tail risks from customer concentration and geopolitics holding it down.
30/100
Amkor (AMKR) Zen Horizon Report
The world's second-largest and the largest U.S.-listed OSAT packaging-and-test house, with advanced packaging (HDFO/2.5D) at roughly 83% of revenue, an AI advanced-packaging portfolio guided to roughly triple in 2026, and Arizona as the only at-scale advanced-packaging capacity on U.S. soil (CHIPS Act subsidy, co-located with TSMC, anchored by Apple and Nvidia). This is a capital-heavy cyclical business running just 14% gross margin and about 6% operating margin, with Apple at roughly 30% of revenue. Rating Watch: a real strategic foothold bought right at the start of a capital-devouring phase, with the market already pricing in zero upside.
36/100
SMIC (0981.HK) Zen Horizon In-Depth Research
China's largest foundry and the only mainland player with advanced-node capability at DUV 7nm, SMIC generated FY25 revenue of USD 9.33 billion with a 21% gross margin, but ROE was only about 3%, free cash flow was about USD -5.2 billion, and profits relied heavily on government subsidies. The core debate is whether strategic indispensability, AI-driven mature-node pricing, and domestic substitution can offset weak returns, heavy capex, and export-control ceilings. Research rating Watch: a strategically important asset, but at the current price the risk-reward is skewed downward.
55/100
Astera Labs (ALAB): A Zen Horizon Report
The purest play on the AI server connectivity bottleneck, spanning four product lines (PCIe/CXL retimers, smart cable modules, CXL memory controllers, and the Scorpio fabric switch) plus the COSMOS software layer. It holds a de facto monopoly in Gen5 retimers, PCIe Gen6 already accounts for one-third of total revenue, FY2025 revenue hit $850 million (+115%), Q1 2026 reached $308 million in a single quarter (+93%), non-GAAP gross margin runs at 76%, GAAP has turned positive, and net cash sits near $1.2 billion. The business is a textbook chokehold. Rating Watch: a first-rate chokehold business priced so richly it leaves no room for any misstep.
46/100
WuXi AppTec Zen Horizon Framework Deep Dive: A Fine Business, a Fair Price, and an Unresolved Geopolitical Catch
WuXi AppTec is the global leader in small-molecule CRDMO, with the highest gross margin among peers and core recurring net profit still up 32.6%. The central thesis is that the business quality remains high, but the H-share price of HKD 125.6 sits only inside a neutral valuation band, lacks a margin of safety, and still carries unresolved BIOSECURE/1260H binary geopolitical risk plus ongoing controlling-shareholder selling. Research rating Watch: a high-quality compounder worth monitoring, but current price and unresolved tail risk do not justify a new-position entry.
42/100
Entegris (ENTG) Zen Horizon Research Report
Entegris is a global leader in semiconductor purification consumables, with about 75% of revenue tied to annuity-like materials consumed as wafers are produced. Its core thesis rests on certified-in filters, CMP slurries, specialty materials and gases, and wafer carriers, with no single product platform above 3% of sales and very high switching costs once qualified into fab processes. Research rating Watch: a high-quality compounder and one of the cleanest AI pick-and-shovel cash-flow stories, but the current price leaves little margin of safety.
45/100
Schneider Electric (SU.PA) Zen Horizon Research Report
Schneider Electric is a global leader in electrical distribution and energy management, with data centers accounting for about 30% of 2025 orders and making it one of the clearest picks-and-shovels suppliers for AI power. FY2025 revenue reached €40.2bn, adjusted EBITA margin was 18.7%, and cash conversion exceeded 100%. Research rating Watch: a first-class compounder already priced near the top of its historical range, where patience for a better entry point matters more than chasing momentum.
49/100
Asia Vital Components: Deep-Dive Research Using the Zen Horizon Framework
Asia Vital Components is the world's largest system thermal solutions manufacturer and a core liquid-cooling supplier for Nvidia AI servers. FY2025 revenue exceeded NT$100 billion with YoY growth of 95%, EPS reached NT$49.17, and Q1'26 EPS hit a record NT$20.17, confirming real acceleration. Report rating Watch: a high-quality AI liquid-cooling leader, but the stock already prices in much of the 2026-2027 upside while short-term momentum has begun to show cracks.
33/100
Redwire: A Long-Term Owner's View — Good Runway, an Unproven Good Company
A space-infrastructure plus defense unmanned-systems platform: demand is real, but commercial quality is unproven, Owner Earnings are still negative, and dilution and internal-control risks run high. At the current 18.62 dollars the stock already sits at the top of an optimistic valuation, leaving no margin of safety. Rating Watch: real demand and option value, but not yet a proven business that compounds cash for common shareholders, and the price has prepaid much of the success.
U.S. Market Close Daily | 2026-06-04
A daily read of where U.S. equities sit after a mixed-but-firm session. The Dow set a record and the S&P edged higher as falling oil and Treasury yields cushioned the tape, while Broadcom's guidance miss capped semiconductors and the Nasdaq. Rating Watch: a record-strong index masks a rotation rather than a broad breakout, so chasing the AI leadership here carries asymmetric risk.